Assyro AI
Orange Book product · Generic (ANDA)

Amitriptyline Hydrochloride

Amitriptyline Hydrochloride

Generic (ANDA)ANDA 085968TE ABRLD Sandoz
Approved
Approved Prior to Jan 1, 1982
Application
Generic (ANDA)
TE code
AB
Listed patents
0
Amitriptyline Hydrochloride (Amitriptyline Hydrochloride) is a generic drug approved under an ANDA (085968), marketed by Sandoz. Its therapeutic-equivalence code is AB, so the FDA considers it substitutable for the reference brand.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

No patent or exclusivity dates are listed for this product.

FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

AMITRIPTYLINE HYDROCHLORIDE

Strength

25MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 085968

Product number

002

Marketing status

Prescription

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Same application

Other strengths in ANDA 085968

Brand + generics

Active-ingredient family

Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amitriptyline Hydrochloride — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Amitriptyline Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.